作者: Robert Schlaberg , Michael J Mitchell , Edward W Taggart , Rosemary C She ,
DOI: 10.5858/ARPA.2011-0138-OA
关键词:
摘要: Context.—US Food and Drug Administration (FDA)–approved diagnostic tests based on molecular genetic technologies are becoming available for an increasing number of microbial pathogens. Advances in ...